Invenomic Capital Management’s Tronox TROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,200,423
Closed -$9.18M 181
2025
Q4
$9.18M Sell
2,200,423
-3,453
-0.2% -$13.2K 0.43% 77
2025
Q3
$8.86M Buy
2,203,876
+922,453
+72% +$4.22M 0.43% 75
2025
Q2
$6.5M Buy
1,281,423
+830,541
+184% +$4.52M 0.37% 86
2025
Q1
$3.17M Buy
450,882
+241,024
+115% +$2.07M 0.16% 136
2024
Q4
$2.11M Buy
+209,858
New +$2.55M 0.1% 145
2022
Q3
Sell
-289,546
Closed -$4.86M 195
2022
Q2
$4.86M Buy
289,546
+1,592
+0.6% +$28.8K 0.34% 82
2022
Q1
$4.61M Buy
287,954
+64,544
+29% +$1.4M 0.49% 64
2021
Q4
$5.37M Sell
223,410
-1,541
-0.7% -$36.9K 1.15% 28
2021
Q3
$5.54M Buy
224,951
+143,409
+176% +$2.95M 1.8% 17
2021
Q2
$1.83M Sell
81,542
-39,418
-33% -$865K 0.44% 45
2021
Q1
$2.21M Buy
120,960
+49,177
+69% +$858K 0.49% 41
2020
Q4
$1.05M Buy
+71,783
New +$835K 0.27% 71

Other funds holding TROX

Invenomic Capital Management's TROX Position: Q1 2026 in Review

Invenomic Capital Management sold out of Tronox (TROX) in Q1 2026, closing a stake of 2,200,423 shares — an estimated $9.18M sold.

Invenomic Capital Management first reported a position in TROX in Q4 2020 and held it in 12 quarters. The position peaked at $9.18M in Q4 2025. 235 funds tracked by Wall St. Rank hold TROX as of Q1 2026.

  • Invenomic Capital Management reported no remaining Tronox position as of Q1 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 2,200,423 Tronox shares in Q1 2026, an estimated $9.18M.
  • Invenomic Capital Management first reported a position in Tronox in Q4 2020 and held it in 12 quarters.
  • Invenomic Capital Management's Tronox position peaked at $9.18M in Q4 2025.
  • 235 funds tracked by Wall St. Rank held Tronox as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.